Search Results - "Hua, Tsushung"

Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks by Mehlum, Maria H, Liestøl, Knut, Kjeldsen, Sverre E, Julius, Stevo, Hua, Tsushung A, Rothwell, Peter M, Mancia, Giuseppe, Parati, Gianfranco, Weber, Michael A, Berge, Eivind

“…Abstract Aims Blood pressure variability is associated with increased risk of cardiovascular events, particularly in high-risk patients. We assessed if…”
Get full text

Effects of Serelaxin in Patients with Acute Heart Failure by Metra, Marco, Teerlink, John R, Cotter, Gad, Davison, Beth A, Felker, G. Michael, Filippatos, Gerasimos, Greenberg, Barry H, Pang, Peter S, Ponikowski, Piotr, Voors, Adriaan A, Adams, Kirkwood F, Anker, Stefan D, Arias-Mendoza, Alexandra, Avendaño, Patricio, Bacal, Fernando, Böhm, Michael, Bortman, Guillermo, Cleland, John G.F, Cohen-Solal, Alain, Crespo-Leiro, Maria G, Dorobantu, Maria, Echeverría, Luis E, Ferrari, Roberto, Goland, Sorel, Goncalvesová, Eva, Goudev, Assen, Køber, Lars, Lema-Osores, Juan, Levy, Phillip D, McDonald, Kenneth, Manga, Pravin, Merkely, Béla, Mueller, Christian, Pieske, Burkert, Silva-Cardoso, Jose, Špinar, Jindřich, Squire, Iain, Stępińska, Janina, Van Mieghem, Walter, von Lewinski, Dirk, Wikström, Gerhard, Yilmaz, Mehmet B, Hagner, Nicole, Holbro, Thomas, Hua, Tsushung A, Sabarwal, Shalini V, Severin, Thomas, Szecsödy, Peter, Gimpelewicz, Claudio

“…In a randomized trial, 6545 patients with acute heart failure were assigned to either serelaxin or placebo in addition to standard care. There were no…”
Get full text

Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure: The ASTRONAUT Randomized Trial by Gheorghiade, Mihai, Böhm, Michael, Greene, Stephen J, Fonarow, Gregg C, Lewis, Eldrin F, Zannad, Faiez, Solomon, Scott D, Baschiera, Fabio, Botha, Jaco, Hua, Tsushung A, Gimpelewicz, Claudio R, Jaumont, Xavier, Lesogor, Anastasia, Maggioni, Aldo P

“…IMPORTANCE Hospitalizations for heart failure (HHF) represent a major health burden, with high rates of early postdischarge rehospitalization and mortality…”
Get full text

Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis by Schneider, Markus P, Hua, Tsushung A, Böhm, Michael, Wachtell, Kristian, Kjeldsen, Sverre E, Schmieder, Roland E

“…The authors reviewed published clinical trial data on the effects of renin-angiotensin system (RAS) inhibition for the prevention of atrial fibrillation (AF),…”
Get full text

Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial by Mancia, Giuseppe, Kjeldsen, Sverre E, Zappe, Dion H, Holzhauer, Björn, Hua, Tsushung A, Zanchetti, Alberto, Julius, Stevo, Weber, Michael A

“…Recent hypertension guidelines recommend that also in high cardiovascular (CV) risk, hypertensive patients blood pressure (BP) is lowered to <140/90 mmHg as no…”
Get full text

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study by Teerlink, John R., Voors, Adriaan A., Ponikowski, Piotr, Pang, Peter S., Greenberg, Barry H., Filippatos, Gerasimos, Felker, G. Michael, Davison, Beth A., Cotter, Gad, Gimpelewicz, Claudio, Boer‐Martins, Leandro, Wernsing, Margaret, Hua, Tsushung A., Severin, Thomas, Metra, Marco

“…Patients admitted for acute heart failure (AHF) experience high rates of in‐hospital and post‐discharge morbidity and mortality despite current therapies…”
Get full text

Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes by Weber, Michael A., MD, Bakris, George L., MD, Jamerson, Kenneth, MD, Weir, Matthew, MD, Kjeldsen, Sverre E., MD, Devereux, Richard B., MD, Velazquez, Eric J., MD, Dahlöf, Björn, MD, Kelly, Roxzana Y., MS, Hua, Tsushung A., PhD, Hester, Allen, PhD, Pitt, Bertram, MD

“…Objectives The aim of this study was to determine which combination therapy in patients with hypertension and diabetes most effectively decreases…”
Get full text

Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study by Cotter, Gad, Voors, Adriaan A., Prescott, Margaret F., Felker, G. Michael, Filippatos, Gerasimos, Greenberg, Barry H., Pang, Peter S., Ponikowski, Piotr, Milo, Olga, Hua, Tsushung A., Qian, Min, Severin, Thomas M., Teerlink, John R., Metra, Marco, Davison, Beth A.

“…Background Growth differentiation factor 15 (GDF‐15) was found to be upregulated in patients with chronic heart failure (HF) and associated with disease…”
Get full text

Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome-an analysis from RELAX-AHF by Voors, Adriaan A., Davison, Beth A., Teerlink, John R., Felker, G. Michael, Cotter, Gad, Filippatos, Gerasimos, Greenberg, Barry H., Pang, Peter S., Levin, Bruce, Hua, Tsushung A., Severin, Thomas, Ponikowski, Piotr, Metra, Marco

“…Aims We studied the characteristics and clinical outcome related to diuretic response and the effects of serelaxin in patients hospitalized for acute heart…”
Get full text

Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study by Felker, G. Michael, Mentz, Robert J., Teerlink, John R., Voors, Adriaan A., Pang, Peter S., Ponikowski, Piotr, Greenberg, Barry H., Filippatos, Gerasimos, Davison, Beth A., Cotter, Gad, Prescott, Margaret F., Hua, Tsushung A., Lopez-Pintado, Sara, Severin, Thomas, Metra, Marco

“…Aims Troponin elevation is common in acute heart failure (AHF) and may be useful for prognostication; however, available data are mixed and many previous…”
Get full text

Usefulness of Heart Rate to Predict Cardiac Events in Treated Patients With High-Risk Systemic Hypertension by Julius, Stevo, MD, ScD, Palatini, Paolo, MD, Kjeldsen, Sverre E., MD, PhD, Zanchetti, Alberto, MD, PhD, Weber, Michael A., MD, McInnes, Gordon T., MD, Brunner, Hans R., MD, Mancia, Giuseppe, MD, PhD, Schork, M. Anthony, PhD, Hua, Tsushung A., PhD, Holzhauer, Bjoern, MS, Zappe, Dion, PhD, Majahalme, Silja, MD, PhD, Jamerson, Kenneth, MD, Koylan, Nevres, MD

“…A high heart rate (HR) predicts future cardiovascular events. We explored the predictive value of HR in patients with high-risk hypertension and examined…”
Get full text

Systolic Blood Pressure and Cardiovascular Outcomes During Treatment of Hypertension by Weber, Michael A., MD, Bakris, George L., MD, Hester, Allen, PhD, Weir, Matthew R., MD, Hua, Tsushung A., PhD, Zappe, Dion, PhD, Dahlof, Bjorn, MD, Velazquez, Eric J., MD, Pitt, Bertram, MD, Jamerson, Kenneth, MD

“…Abstract Objective Randomized controlled trials in hypertension demonstrate cardiovascular benefits when systolic blood pressures are reduced from higher…”
Get full text

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial by Julius, Stevo, Kjeldsen, Sverre E, Weber, Michael, Brunner, Hans R, Ekman, Steffan, Hansson, Lennart, Hua, Tsushung, Laragh, John, McInnes, Gordon T, Mitchell, Lada, Plat, Francis, Schork, Anthony, Smith, Beverly, Zanchetti, Alberto

“…The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial was designed to test the hypothesis that for the same blood-pressure control, valsartan…”
Get full text

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial by Schmieder, Roland E, Kjeldsen, Sverre E, Julius, Stevo, McInnes, Gordon T, Zanchetti, Alberto, Hua, Tsushung A

“…BACKGROUNDAtrial fibrillation (AF) is the most common arrhythmia and increases cardiovascular risk in hypertensive patients. Therefore, in the Valsartan…”
Get full text

Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study by Felker, G Michael, Teerlink, John R, Butler, Javed, Hernandez, Adrian F, Miller, Alan B, Cotter, Gad, Davison, Beth A, Filippatos, Gerasimos, Greenberg, Barry H, Ponikowski, Piotr, Voors, Adriaan A, Hua, Tsushung A, Severin, Thomas M, Unemori, Elaine, Metra, Marco

“…Little is known about mode of death after acute heart failure (AHF) hospitalization. In the RELAX-AHF (Efficacy and Safety of Relaxin for the Treatment of…”
Get full text

Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial by Greene, Stephen J., Maggioni, Aldo P., Fonarow, Gregg C., Solomon, Scott D., Böhm, Michael, Kandra, Albert, Prescott, Margaret F., Reimund, Bernard, Hua, Tsushung A., Lesogor, Anastasia, Zannad, Faiez, Gheorghiade, Mihai

“…Aims The purpose of this study was to determine the prognostic significance and associated clinical profile of early post‐discharge N‐terminal pro‐B‐type…”
Get full text

Impact of New-Onset Diabetes Mellitus on Cardiac Outcomes in the Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial Population by Aksnes, Tonje A, Kjeldsen, Sverre E, Rostrup, Morten, Omvik, Per, Hua, Tsushung A, Julius, Stevo

“…There has been a lot of interest about new-onset diabetes mellitus in recent hypertension trials, but the implications of diabetes development on cardiac…”
Get full text

Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial by Maria H. Mehlum, Knut Liestøl, Torgeir B. Wyller, Tsushung A. Hua, Morten Rostrup, Eivind Berge

“…Purpose: Blood pressure variability is associated with traditional cardiovascular risk factors, but little is known about the association with atrial…”
Get full text

No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial by Kjeldsen, Sverre E, Berge, Eivind, Bangalore, Sripal, Messerli, Franz H, Mancia, Giuseppe, Holzhauer, Björn, Hua, Tsushung A, Zappe, Dion, Zanchetti, Alberto, Weber, Michael A, Julius, Stevo

“…Previous studies have debated the notion that low blood pressure (BP) during treatment, particularly diastolic (DBP), is associated with increased risk of…”
Get more information

Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF by Metra, Marco, Ponikowski, Piotr, Cotter, Gad, Davison, Beth A, Felker, G Michael, Filippatos, Gerasimos, Greenberg, Barry H, Hua, Tsushung A, Severin, Thomas, Unemori, Elaine, Voors, Adriaan A, Teerlink, John R

“…Patients hospitalized for acute heart failure (AHF) differ with respect of many clinical characteristics which may influence their prognosis and response to…”
Get full text